Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kania Edwin M Jr
Relationship:   10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   11,446,567    

Indirect Shares

   62,961,806      
Direct Value   $115,556,491    

Indirect Value

   $160,922,477      
Total Shares   74,408,373      
Total Value   $276,478,968      


Exact Sciences Corp $7,840,261 Tetraphase Pharmaceuticals Inc $275,125 Acceleron Pharma Inc $5,136,203 Carisma Therapeutics Inc $2,580,983 Concert Pharmaceuticals, Inc. $5,494,821 Selecta Biosciences Inc $13,373 Syros Pharmaceuticals, Inc. $12,131,181 Editas Medicine, Inc. $14,374,131 Quanterix Corp $32,427,005 Moderna, Inc. $0 Transmedics Group, Inc. $35,283,406 Exact Sciences Corp $7,840,261 Tetraphase Pharmaceuticals Inc $275,125 Acceleron Pharma Inc $5,136,203 Carisma Therapeutics Inc $2,580,983 Concert Pharmaceuticals, Inc. $5,494,821 Selecta Biosciences Inc $13,373 Syros Pharmaceuticals, Inc. $12,131,181 Editas Medicine, Inc. $14,374,131 Quanterix Corp $32,427,005 Moderna, Inc. $0 Transmedics Group, Inc. $35,283,406
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   115.9%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Exact Sciences Corp EXAS Director 2009-07-20 172,503 2009-07-20 1,202,787    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH 10% Owner 2013-03-25 1,165,786 2013-03-25 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2014-12-23 28,734 2014-12-23 544,055    Premium*  
            DNIB Upwind Inc BIND 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Carisma Therapeutics Inc CARM 10% Owner 2016-09-23 1,940,589 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE 10% Owner 2014-02-19 656,490 0    Premium*  
            T2 Biosystems, Inc. TTOO 10% Owner 2014-08-12 0 2014-08-12 2,374,571    Premium*  
            Bg Medicine, Inc. BGMD 10% Owner 2014-12-04 0 2014-12-11 4,915,402    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 0 2016-05-25 0    Premium*  
            Selecta Biosciences Inc SELB Director 2017-05-16 26,528 2017-05-16 560,067    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2017-08-17 2,378,663 2017-08-17 262,386    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-08-11 2,764,256 2016-08-11 45,422    Premium*  
            Quanterix Corp QTRX 10% Owner 2017-12-11 2,030,495 2017-12-11 0    Premium*  
            Evelo Biosciences Inc EVLO 10% Owner 2018-05-11 0 2018-05-11 18,233,403    Premium*  
            Rubius Therapeutics, Inc. RUBY 10% Owner 2018-07-20 0 2018-07-20 7,563,703    Premium*  
            Moderna, Inc. MRNA 10% Owner 2020-01-14 23,847 2019-12-11 20,253,972    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2019-03-04 2,682,840    Premium*  
            Transmedics Group, Inc. TMDX 2024-05-23 258,676 2024-05-23 46,142    Premium*  
            Axcella Health Inc. AXLA 10% Owner 0 2019-05-08 2,714,440    Premium*  
* Premium Members only  

Records found :    79         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EXAS Exact Sciences Corp Director   –       •      –    2007-08-10 4 A $3.00 $30,000 D/D 10,000 96,820 0 -
EXAS Exact Sciences Corp Director   –       •      –    2008-07-18 4 A $0.71 $7,100 D/D 10,000 106,820 0 -
EXAS Exact Sciences Corp Director   –       •      –    2009-01-02 4 A $0.00 $0 D/D 60,344 167,164 0 -
EXAS Exact Sciences Corp Director   –       •      –    2009-07-20 4 A $0.00 $0 D/D 5,339 172,503 0 -
KLDO Kaleido Biosciences, Inc. 10% Owner   –       –       •   2019-02-27 3 IO $0.00 $0 I/I 0 1,735,729 -
KLDO Kaleido Biosciences, Inc. 10% Owner   –       –       •   2019-03-04 4 A $0.00 $0 I/I 1,120,697 947,111 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2015-06-25 3 IO $0.00 $0 I/I 0 3,055,556 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2015-06-26 4 A $0.00 $0 I/I 11,627,320 599,297 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2016-05-25 4 D $0.00 $0 I/I (1,033,514) 0 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2016-05-25 4 A $0.00 $0 I/I 33,514 33,514 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2016-05-25 4 S $27.60 $27,600,000 I/I (1,000,000) 0 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2018-12-11 4 A $0.00 $0 I/I 47,343,020 9,468,596 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2019-12-09 4 S $18.99 $3,269,607 I/I (172,137) 8,233,224 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2019-12-09 4 D $0.00 $0 I/I (9,235,720) 0 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2019-12-10 4 S $18.81 $1,880,840 D/D (100,000) 498,847 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2019-12-10 4 S $18.96 $481,871 I/I (25,417) 8,229,132 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2019-12-11 4 S $18.65 $4,445,457 I/I (238,301) 8,190,766 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2020-01-10 4 S $20.34 $7,269,972 D/D (357,375) 141,472 0 -
MRNA Moderna, Inc. 10% Owner   –       –       •   2020-01-14 4 S $20.01 $2,353,841 D/D (117,625) 23,847 0 -
QTRX Quanterix Corp 10% Owner   –       –       •   2017-12-11 4 A $0.00 $0 D/D 2,030,495 2,030,495 0 -
RUBY Rubius Therapeutics, Inc. 10% Owner   –       –       •   2018-07-20 4 A $0.00 $0 I/I 33,296,526 2,563,703 0 -
SELB Selecta Biosciences Inc Director   –       •       •   2016-06-21 3 IO $0.00 $0 I/I 0 31,115 -
SELB Selecta Biosciences Inc Director   –       •      –    2016-06-27 4 A $0.00 $0 I/I 1,620,747 1,651,862 0 -
SELB Selecta Biosciences Inc Director   –       •      –    2017-05-16 4 S $14.00 $3,735,130 I/I (266,795) 560,067 0 -
SYRS Syros Pharmaceuticals, In... 10% Owner   –       –       •   2016-06-29 3 IO $0.00 $0 I/I 0 213,332 -
  79  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us